Immediate Impact
2 by Nobel laureates 10 from Science/Nature 55 standout
Citing Papers
Late-stage Functionalization for Improving Drug-like Molecular Properties
2023 Standout
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023 Standout
Works of David Anderson being referenced
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study
2022
The I ntelence aNd pRezist a O nce A D ay S tudy (INROADS ): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV ‐1‐infected early treatment‐experienced subjects
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Anderson | 464 | 412 | 280 | 45 | 970 | |
| Dénes Bánhegyi | 524 | 589 | 202 | 55 | 1.1k | |
| Maximilian Muenchhoff | 228 | 567 | 226 | 47 | 1.0k | |
| Anne Krivine | 395 | 599 | 466 | 40 | 1.1k | |
| Lewis McCurdy | 317 | 441 | 449 | 38 | 988 | |
| Dan Ouchi | 336 | 419 | 140 | 49 | 748 | |
| Christine Armbruster | 316 | 212 | 244 | 50 | 895 | |
| Edward D. Blair | 508 | 472 | 363 | 27 | 1.1k | |
| Meagan P. O’Brien | 384 | 360 | 342 | 35 | 1.0k | |
| David M. Tehrani | 577 | 216 | 228 | 38 | 1.1k | |
| D. Torre | 134 | 187 | 316 | 47 | 798 |
All Works
Login with ORCID to disown or claim papers
Loading papers...